What AI is actually doing in your industry.

Lilly names Mount Sinai scientist as first chief AI officer - BioPharma Dive

Eli Lilly has appointed its first chief AI officer, a scientist recruited from Mount Sinai, signalling a formal push to embed AI across its drug development and operations. For pharma companies, this reflects a broader trend of large drugmakers creating dedicated senior roles to lead AI strategy. It suggests AI is becoming a board-level priority in the sector rather than a side project.